MedPath

DANONE NORTH AMERICA

🇺🇸United States
Ownership
-
Established
1977-01-01
Employees
-
Market Cap
-
Website
https://www.danonenorthamerica.com/

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Comparison of Plant and Animal Proteins on Amino Acid Concentrations

Not Applicable
Completed
Conditions
Healthy Resistance-Trained Males
First Posted Date
2018-09-17
Last Posted Date
2018-11-26
Lead Sponsor
Danone North America
Target Recruit Count
20
Registration Number
NCT03673839
Locations
🇨🇦

Glycemic, Index Laboratories, Inc., Toronto, Ontario, Canada

News

Probiotics Show Promise in Mitigating Toxic Effects of Fire Retardant Chemicals

A new study shows that the probiotic _Limosilactobacillus reuteri_ (LR) can reduce the negative impacts of polybrominated diphenyl ethers (PBDEs) on neurodevelopment, behavior, and metabolism in mice.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.